Managing Toxicities from Chronic Myeloid Leukemia Treatment
2 Visualizzazioni
• 07/08/23
0
0
Incorporare
administrator
Iscritti
The panelists, Jorge Cortes, MD; Javier Pinilla-Ibarz, MD, PhD; Kevin Kelly, MD, PhD; David Snyder, MD, FACP; and Harry Erba, MD, PhD, comment on strategies to manage adverse events from tyrosine kinase inhibitor therapy used in the treatment of chronic myeloid leukemia.
Mostra di più
Commenti su Facebook
SORT BY-
I migliori commenti
-
Ultimi commenti